PTH and osteoporosis: Compared to subjects in U-CP, those belonging to FLS-CP showed higher adherence to vitamin D supplementation plus calcium (Fig. 2A), to specific anti-osteoporosis drugs, i.e., BPs, denosumab, or PTH analogs (Fig. 2B), and complete anti-osteoporosis treatments (Fig. 2C) in all time points.